- Pre-market US stocks experienced notable movements driven by corporate earnings, asset sales, and business mergers.
- NetEase shares rose 7.14 % following its strong Q2 2026 financial report with 30,100,000,000 yuan in net revenue and subsequent target price upgrades.
- RF Acquisition Corp II surged 405.81 % after shareholders approved a business merger, while Werewolf Therapeutics gained 130.43 % from a platform sale and licensing deal.